WD40 REPEAT DOMAIN PROTEIN 5 (WDR5) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE
Disclosed herein are WD40 repeat domain protein 5 (WDR5) degradation / disruption compounds including a WDR5 ligand, a degradation / disruption tag, and a linker, and methods of using such compounds in the treatment of WDR5-mediated diseases..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Europäisches Patentamt - (2019) vom: 26. Dez. Zur Gesamtaufnahme - year:2019 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
JIN JIAN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2019-12-26, Last update posted on www.tib.eu: 2024-03-04, Last updated: 2024-03-08 |
|---|
| Patentnummer: |
CA3104298 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA007335598 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA007335598 | ||
| 003 | DE-627 | ||
| 005 | 20240308100923.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2019 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA007335598 | ||
| 035 | |a (EPA)CA3104298 | ||
| 035 | |a (EPA)68984318 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a JIN JIAN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a WD40 REPEAT DOMAIN PROTEIN 5 (WDR5) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2019-12-26, Last update posted on www.tib.eu: 2024-03-04, Last updated: 2024-03-08 | ||
| 520 | |a Disclosed herein are WD40 repeat domain protein 5 (WDR5) degradation / disruption compounds including a WDR5 ligand, a degradation / disruption tag, and a linker, and methods of using such compounds in the treatment of WDR5-mediated diseases. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a WANG GANG |4 aut | |
| 700 | 0 | |a LIU JING |4 aut | |
| 700 | 0 | |a YU XUFEN |4 aut | |
| 700 | 0 | |a LI DONGXU |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2019) vom: 26. Dez. |
| 773 | 1 | 8 | |g year:2019 |g day:26 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/68984318/publication/CA3104298A1?q=CA3104298 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2019 |b 26 |c 12 | ||